Project Details
Description
TOPK inhibition by ADA-07 enhances PD-1 immunotherapy via PRPK/PD-L1 axis reprogramming in cutaneous squamous cell carcinoma
| Status | Active |
|---|---|
| Effective start/end date | 11/21/25 → 11/20/26 |
Funding
- VENN FOUNDATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.